News & Updates

Irinotecan mono, doublet therapy: Similarly effective for gallbladder cancers?

02 Sep 2020 by

Irinotecan monotherapy may be as effective as an irinotecan-containing doublet therapy for second-line chemotherapy (CT) for individuals with advanced gallbladder cancers (GBCs) who are progressing on first-line CT, the phase II GB SELECT trial has shown.

Irinotecan mono, doublet therapy: Similarly effective for gallbladder cancers?

02 Sep 2020

Drug-free remission of HIV seen in ‘elite controllers’

02 Sep 2020 by

Elite HIV controllers—those who can control viral replication without medications—have fewer proviral sequences, a recent study has found. These viral genomes appear to be more concentrated in inaccessible and transcriptionally repressed areas of the genome.

Drug-free remission of HIV seen in ‘elite controllers’

02 Sep 2020

Long-term methotrexate therapy may be discontinued in stable RA patients

02 Sep 2020 by

More than half of rheumatoid arthritis (RA) patients achieving low disease activity on long-term methotrexate (MTX) remain flare-free following its withdrawal, as shown in a study. The use of a higher MTX dose to preserve low disease activity is predictive of disease flare after discontinuation.

Long-term methotrexate therapy may be discontinued in stable RA patients

02 Sep 2020

Serum amyloid A a valuable biomarker in acute anterior uveitis

02 Sep 2020

Patients with acute anterior uveitis (AAU) see elevated levels of serum amyloid A (SAA), which may help in monitoring inflammatory processes and assess the efficacy of therapies, a recent study has found.

Serum amyloid A a valuable biomarker in acute anterior uveitis

02 Sep 2020

NCDs continue with march in the shadow of COVID-19

02 Sep 2020 by

The most recent report by the National Health and Morbidity Survey (NHMS) 2019 proved to be a blow to public health in Malaysia. Even with consistent, unrelenting efforts by stakeholders and policymakers, the figures for NCDs continue to climb. MIMS Doctor reached out to the Director-General of Health Tan Sri Dato' Seri Dr Noor Hisham Abdullah to get up to date with the COVID-19 situation in the country and to obtain his thoughts on the ramifications of the findings.

NCDs continue with march in the shadow of COVID-19

02 Sep 2020

Decentralized HCV testing is key to finding the missing millions

02 Sep 2020 by

The Foundation for Innovative New Diagnostics (FIND) in partnership with the World Hepatitis Alliance (WHA) and the Drugs for Neglected Diseases initiative (DNDi) organized a webinar on 30 July 2020, in conjunction with World Hepatitis Day which showcased preliminary outcomes from the Unitaid-supported Hepatitis C Elimination through Access to Diagnostics (HEAD-Start) project. The Ministry of Health (MOH) representatives from each project country, including Malaysia, presented project outcomes from their respective country.

Decentralized HCV testing is key to finding the missing millions

02 Sep 2020

Spironolactone potentially chemopreventive in men

02 Sep 2020

Exposure to the diuretic spironolactone may reduce the risk of developing prostate cancer by about 17 percent, a study has found.

Spironolactone potentially chemopreventive in men

02 Sep 2020

Original New Drug Application Approvals by US FDA (16 - 31 August 2020)

02 Sep 2020

New drug applications approved by US FDA as of 16 - 31 August 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 August 2020)

02 Sep 2020

Lower CRC risk with ACEis, ARBs?

01 Sep 2020 by

The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may be associated with a reduced risk of colorectal cancer (CRC), according to a retrospective cohort study from Hong Kong.

Lower CRC risk with ACEis, ARBs?

01 Sep 2020

Probiotics protect against death, NEC in preemies

01 Sep 2020

Probiotics appear to be beneficial to preterm, low-birthweight infants, reducing the risk of death and necrotizing enterocolitis, reports a new meta-analysis.

Probiotics protect against death, NEC in preemies

01 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

Irinotecan mono, doublet therapy: Similarly effective for gallbladder cancers?

Irinotecan mono, doublet therapy: Similarly effective for gallbladder cancers?

Drug-free remission of HIV seen in ‘elite controllers’

Drug-free remission of HIV seen in ‘elite controllers’

Long-term methotrexate therapy may be discontinued in stable RA patients

Long-term methotrexate therapy may be discontinued in stable RA patients

Serum amyloid A a valuable biomarker in acute anterior uveitis

Serum amyloid A a valuable biomarker in acute anterior uveitis

NCDs continue with march in the shadow of COVID-19

NCDs continue with march in the shadow of COVID-19

Decentralized HCV testing is key to finding the missing millions

Decentralized HCV testing is key to finding the missing millions

Spironolactone potentially chemopreventive in men

Spironolactone potentially chemopreventive in men

Original New Drug Application Approvals by US FDA (16 - 31 August 2020)

Original New Drug Application Approvals by US FDA (16 - 31 August 2020)

Lower CRC risk with ACEis, ARBs?

Lower CRC risk with ACEis, ARBs?

Probiotics protect against death, NEC in preemies

Probiotics protect against death, NEC in preemies